EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan

Takuto Hara iD, Yuto Matsushita iD, Kenichi Harada iD, Naohiro Fujimoto iD, Masato Fujisawa, Hideaki Miyake

International Journal of Urology · 2024

DOI: 10.1111/iju.15435 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2024. Verfasst von Takuto Hara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Antibodies, Monoclonal, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Transitional CellAntibodies, MonoclonalUrinary Bladder NeoplasmsHumansRetrospective StudiesJapanMaleAgedFemaleMiddle AgedTreatment OutcomeAged, 80 and over

Substanzen

Antibodies, Monoclonalenfortumab vedotin

Autor:innen und Institutionen

  • Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan.

ORCID-Profile: Takuto Hara, Yuto Matsushita, Kenichi Harada, Naohiro Fujimoto

Zitieren

APA

Hara, T., Matsushita, Y., Harada, K., Fujimoto, N., Fujisawa, M., & Miyake, H. (2024). Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan. International Journal of Urology. https://doi.org/10.1111/iju.15435

Vancouver

Hara T, Matsushita Y, Harada K, Fujimoto N, Fujisawa M, Miyake H. Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan. International Journal of Urology. 2024. doi:10.1111/iju.15435

BibTeX
@article{Hara2024,
  author = {Hara, Takuto and Matsushita, Yuto and Harada, Kenichi and Fujimoto, Naohiro and Fujisawa, Masato and Miyake, Hideaki},
  title = {Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15435}
}
Kostenlos starten →